Shire rises on Astrazenca bid talk: traders
LONDON (Reuters) - Shares in Shire (SHP.L) gained 2.3 percent in brisk volume on Wednesday, bucking a weaker European stock market, with traders citing rehashed talk of a potential bid from UK-listed pharmaceutical peer AstraZeneca (AZN.L).
Shire's stock had traded 70 percent of its full-day volume average at 1341 GMT and it was among the top risers on the pan-European FTSEurofirst 300 index .FTEU3, down 0.3 percent.
AstraZeneca said it did not comment on market rumours, while Shire was unavailable for comment.
(Written by David Brett; Editing by Francesco Canepa)
- U.S. small businesses boosted borrowing in October to its highest level in over six years, an index showed on Tuesday, fresh evidence that the budget battle that shut the federal government for 16 days did little to derail underlying economic growth.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.